Related Experiment Video
Updated: Mar 23, 2026
11:56
A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
Published on: April 11, 2014
14.0K
Ascorbic acid serum levels are reduced in patients with hematological malignancies
Mirelle J A J Huijskens1, Will K W H Wodzig2, Mateusz Walczak1
1Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.
Results in Immunology
|March 26, 2016
Summary
Patients undergoing chemotherapy or stem cell transplants show significantly lower ascorbic acid (AA) levels. Ascorbic acid may support immune cell growth, suggesting potential benefits of AA supplementation after intensive treatments.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Chemotherapy and hematopoietic stem cell transplantation (HSCT) are intensive treatments.
- Immune cell recovery is critical following these therapies.
- Serum ascorbic acid (AA) levels are often unexamined in these patient populations.
Purpose of the Study:
- To investigate serum ascorbic acid (AA) levels in patients undergoing chemotherapy and/or HSCT.
- To explore the relationship between AA levels and immune cell function post-treatment.
- To assess the potential impact of AA supplementation on immune recovery.
Main Methods:
- Comparison of serum AA levels between patients and healthy controls.
- In vitro assessment of AA's effect on T and NK cell growth from hematopoietic stem cells.
- Correlation analysis between AA levels and immune cell function.
Main Results:
- Patients treated with chemotherapy and/or HSCT exhibited significantly reduced serum AA levels compared to healthy individuals.
- In vitro studies indicated that AA positively influences the growth of T and NK cells derived from hematopoietic stem cells.
Conclusions:
- Intensive cancer treatments like chemotherapy and HSCT are associated with decreased ascorbic acid (AA) levels.
- AA may play a role in supporting immune cell proliferation, particularly T and NK cells.
- Further research into AA supplementation for immune recovery post-treatment is warranted.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
01:11Renal Failure: Dose Adjustments
574
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
574
01:22Bone Marrow Sampling and Transplants
2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
335
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
335
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
01:27Disorders of Erythrocytes
2.8K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.8K